James K. Drennen received a $237,000 grant from the Food and Drug Administration on a subcontract with the National Institute for Pharmaceutical Technology and Education for “QDB Approach to Process Development: Defining Critical Quality Attributes, Evaluating Critically Across Scales, and Relating Variations in CPPS/CQAS to Product Performance.”
Jennifer Elliott received a two-year, $177,000 award from the Jefferson Regional Foundation to support a project that will provide surveillance and treatment of asthma in Clairton schoolchildren. The award will extend through June 2017.
Rehana Leak received a $382,931, three-year R-15 award from the National Institutes of Health, National Institute of Neurological Disorders and Stroke, for “Impact of N-acetyl Cysteine Ethyl Ester on A-synuclein Pathology in the Olfactory System.” The grant extends through June 30, 2018.
Wilson Meng received funding on a grant from the National Institutes of Health, National Institute of Allergy and Infectious Diseases, in the amount of $139,464 for year two of a two-year award. The funds are to be used for a project “A Biomaterial Approach to Attenuate Rejection of Skin Allografts.” Year two of the award will run from Aug. 1, 2015 through July 31, 2016. These are federal funds to be used for research.
Jamie L. McConaha received a $10,000 grant from Pfizer Inc., for the smoking cessation program “Courage to Quit.” This brings the total award amount to date to $30,000.
Sidhartha D. Ray has been named the editor of the monograph Side Effects of Drugs Annual or SEDA.
Jason Richardson received funding from Rutgers University in the amount of $341,100 to support the project “Developing Drugs to Mitigate Parathion Intoxication.” Original source of funds is the National Institute of Health, National Institute of Neurological Disorders and Stroke.
Medical Mutual of Ohio has provided a $1 million philanthropic commitment to fund 14, four-year scholarships for NEOMED Doctor of Pharmacy students.
Arun K. Ghosh received $480,010 from PHS-NIH National Institute of General Medical Science for “Design & Synthesis of Nonpeptide Protease Inhibitors.”
Marlene O. Heeg received $50,000 from Spectrum Pharmaceuticals for “Positioning New and Emerging Regimens to Optimize Multiple Myeloma Treatment.” She also received $90,000 from Janssen Scientific Affairs for Applying the Latest Evidence and Recommendations to Deliver Interdisciplinary, Patient-Centered Care to Patients with Castrate-Resistant Prostate Cancer in the Veterans Health; $123,819 from Forest Research Institute, Inc. for Contemporary Multiple Sclerosis Management: Identifying and Overcoming Challenges in the Managed Care Setting; and $200,000 from Abbvie Inc. for 2015 National Educational Initiative on Therapeutics & Rheumatology for Rheumatology State Societies.
Additionally, Heeg received $277,038 from Shire Pharmaceuticals for Dry Eye & Ocular Surface Disease (R); $200,000 from Novartis Pharmaceuticals for MS Forum 2015; and 300,000 from Janssen Therapeutics for 2015-2016 GALA HCV Resistance Educational Series.
Karen S. Hudmon received $250,000 from Indiana State Department of Health for Bringing Indiana Along.
Carol B. Post received $319,315 from PHS-NIH National Institute of General Medical Science for Nuclear Magnetic Resonance (NMR) Structure of Peptide and Protein Complexes.
Jean-Christophe Rochet received $200,000 from Branfman Family Foundation for Vesicle Permeabilization Associated with Membrane-Induced aSyn Aggregation: Role in Parkinson’s Disease.
Jean-Christophe Rochet received $83,659 from University of Minnesota for Multiplexed Kinase Biosensor Technology to Detect Leukemia Signaling with Mass Spectrometry.
Margie E. Snyder, Karen S. Hudmon and Michael D. Murray received $144,197 from PHS-AHRQ (Agency for Healthcare Research & Quality) for Optimizing Medication Therapy Management for Chronically Ill Medicare Part D Beneficiaries.
Lynne S. Taylor received $442,917 from U.S. Department of Education for Pharmaceutical Engineering 2015 Graduate Assistance in Areas of National Need (GAANN) and $265,000 from Lilly Research Laboratories for The Effect of Compound Aggregation on Drug Metabolism and Transport.
Lynne S. Taylor and Raymond E. Galinsky received $500,000 from PHS-FDA Food and Drug Administration for Formulation, Processing and Performance Interrelationships for Amorphous Solid Dispersions.
James E. Tisdale, Brian R. Overholser and Kevin M. Sowinski received $143,000 from the American Heart Association for Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades De Pointes.
Richard M. van Rijn received $237,370 from PHS-NIH National Institute on Alcohol Abuse for Development of a Pre-clinical Candidate for the Treatment of Alcoholism.
Val J. Watts received $446,858 from National Institutes of Health for “Understanding Adaptive Signaling of Neuronal Adenyly Cyclases Using Sirna.”
Kara D. Weatherman received $10,000 from Cardinal Health for “Nuclear Pharmacy Educational Efforts and Radio-pharmaceutical Safety.”
Michael K. Wendt received $20,000 from Indiana University for “Establishment of Differential Isoform Expression as a Biomarker for FGFR Targeted Therapy.”
Roland N. Dickerson was honored as this year’s recipient of the American College of Clinical Pharmacy Clinical Practice Award.
Shaun Rowe was honored with the Neurocritical Care Society Presidential Service Award.
Junling Wang received a $987,562 grant from the National Institute on Aging and will be funded over the next three years. The purpose of this grant is to research more equitable and effective eligibility criteria for MTM for Medicare beneficiaries.
Andrea S. Franks is a co-investigator for the Recovery Based Interprofessional Distance Education (RIDE) program funded by HRSA. The RIDE program is an interprofessional education collaboration to teach students to provide recovery-focused care to individuals with mental health needs as part of an interdisciplinary team.
Carolyn Ma has been appointed interim dean of the University of Hawaii at Hilo Daniel K. Inouye College of Pharmacy.
Laura Sanchez has been named Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) Scholar.
Karol Bruzik received $229,818 in continuation funding as a UIC co-investigator on NIH/NIGMS P01 project “General Anesthetic Sites on Ligand-Gated Ion Channels” awarded to Massachusetts General Hospital.
Richard A. Gemeinhart and his collaborator Karen Colley received funding for the 2015 Cancer Center Pilot Project “Targeting polysialic acid-modified surface markers in lung cancer therapy.
Hyunyoung Jeong received $7,246 in continuation funding as a subcontract PI on NIH/NIMHHD R01 grant with University of Chicago’s Minoli Perera for “Health Disparity in Pharmacogenomics: African American SNPs and Drug Metabolism.”
Alan Kozikowski received $118,893 as a subcontract PI on NIH/NCI R01 grant “RAD51 Inhibitors for Chemotherapy and Radiation Therapy.” He is collaborating with University of Chicago’s Phil Connell.
Alexander Mankin received $88,165 from Cempra Inc. for “Mode of Action of Solithromycin.”
Terry W. Moore received $50,000 in new funding from Michael Reese Research & Education Foundation for his project “Nrf2 Activators to Treat Idiophathic Pulmonary Fibrosis.”
Keith Rodvold received $21,474 in supplemental funding as a subcontract PI on NIH/NIAID research project cooperative agreement “ARLG: Leadership Group for a Clinical Research Network on Antibacterial Resistance.”
John D. Bucheit has been named an assistant professor, Department of Pharmacotherapy and Outcomes Science’s ambulatory care group, effective Jan. 29.
Youzhong Guo has been named an assistant professor, Department of Medicinal Chemistry, effective in February.
Kristin Zimmerman has been named an associate professor, Department of Pharmacotherapy and Outcomes Science’s ambulatory care group, effective Jan. 1.
Bhanupriya Madarampalli was appointed as an associate in the Department of Pharmaceutical Sciences.
Joshua Neumiller was appointed to serve as the director for the WSU College of Pharmacy Office of Experiential Services.
Julie Akers received $62,260 over a one year and five month period from the Community Pharmacy Foundation for the research project, “Increasing access to point-of-care screening for Hepatitis C in community pharmacies.”
Philip Lazarus received $2,649,758 over five years from the National Institutes of Health for the research project, The UGT2A and 3A metabolizing enzymes and tobacco-related cancer risk.
Joshua Neumiller received additional funding in the amount of $49,960 over a four month period from the Patient-Centered Outcomes Research Institute (PCORI) for the research project, “Preserving self: empowering older persons with multiple chronic medical conditions.”
Jiyue Zhu received $400,888 over two years from the National Institutes of Health (R21) for the project, “Development of mouse strains with human-like telomerase regulation.” The project aims to develop a better mouse model for human aging, cancer, and other diseases by creating mouse strains with human-like telomere homeostasis.
Edward Fisher has been selected to serve as dean of the College of Pharmacy at Marshall B. Ketchum University in Fullerton, California.
Jackie Huck was recognized as an honorary member of the University of Saskatchewan Alumni Association.
Kishor M. Wasan and his colleagues at the University of Copenhagen won the 2015 American Association of Pharmaceutical Sciences Lipid Based Focus Group Poster Award for their work “In Vivo Precipitation of Poorly Soluble Drugs from Lipid Based Formulations.”
Kishor M. Wasan was also presented a recognition award from the Members of the American Association of Pharmaceutical Scientists Global Health Focus Group for work supporting, educating and training young scientists as global health professionals.
The College of Pharmacy and Nutrition was one of ten pharmacy schools selected in a global search for this year’s American Association of Pharmaceutical Scientists video series.
Charity Evans was part of a team that received a three-year Clinical and Population Health Operating grant from The Multiple Sclerosis Society of Canada, to assess the safety monitoring of patients taking MS oral treatments.